AAAAAA

   
Results: 1-11 |
Results: 11
PHASE-I TRIAL OF THE COLLOIDAL DISPERSION FORMULATION OF 9-AMINO-20(S)-CAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION
Authors: EDER JP SUPKO JG LYNCH T BRYANT M VOSBURGH E SHULMAN LN XU GX KUFE DW
Citation: Jp. Eder et al., PHASE-I TRIAL OF THE COLLOIDAL DISPERSION FORMULATION OF 9-AMINO-20(S)-CAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Clinical cancer research, 4(2), 1998, pp. 317-324
PHASE-I TRIAL OF THE COLLOIDAL DISPERSION FORMULATION OF 9-AMINO-20(S)-CAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION
Authors: EDER JP SUPKO JG LYNCH T BRYANT M VOSBURGH E SHULMAN LN XU GX KUFE DW
Citation: Jp. Eder et al., PHASE-I TRIAL OF THE COLLOIDAL DISPERSION FORMULATION OF 9-AMINO-20(S)-CAMPTOTHECIN ADMINISTERED AS A 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Clinical cancer research, 4(2), 1998, pp. 317-324
SEQUENCE EFFECT OF IRINOTECAN (CPT-11) AND TOPOISOMERASE-II INHIBITORS IN-VIVO
Authors: EDER JP CHAN V WONG J WONG YW ARA G NORTHEY D RIZVI N TEICHER BA
Citation: Jp. Eder et al., SEQUENCE EFFECT OF IRINOTECAN (CPT-11) AND TOPOISOMERASE-II INHIBITORS IN-VIVO, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 327-335
A 67-YEAR-OLD WOMAN WITH A PROGRESSIVE MOVEMENT DISORDER AND A LEFT-UPPER-QUANDRANT MASS - HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE (VOL 337, PG 115, 1997)
Authors: EDER JP
Citation: Jp. Eder, A 67-YEAR-OLD WOMAN WITH A PROGRESSIVE MOVEMENT DISORDER AND A LEFT-UPPER-QUANDRANT MASS - HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE (VOL 337, PG 115, 1997), The New England journal of medicine, 338(1), 1998, pp. 71-71
IRINOTECAN AND RADIATION IN-VITRO AND IN-VIVO
Authors: EDER JP WONG JS CHAN V TEICHER BA
Citation: Jp. Eder et al., IRINOTECAN AND RADIATION IN-VITRO AND IN-VIVO, International journal of oncology, 11(6), 1997, pp. 1235-1240
A 67 YEAR-OLD WOMAN WITH A PROGRESSIVE MOVEMENT DISORDER AND A LEFT-UPPER-QUADRANT MASS - HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE - PARANEOPLASTIC CEREBELLAR DEGENERATION
Authors: EDER JP NGUYEN P KOCH JS NIKRUI N
Citation: Jp. Eder et al., A 67 YEAR-OLD WOMAN WITH A PROGRESSIVE MOVEMENT DISORDER AND A LEFT-UPPER-QUADRANT MASS - HODGKINS-DISEASE, NODULAR-SCLEROSIS TYPE - PARANEOPLASTIC CEREBELLAR DEGENERATION, The New England journal of medicine, 337(2), 1997, pp. 115-122
MOLECULAR-CLONING AND CHARACTERIZATION OF THE PROMOTER FOR THE CHINESE-HAMSTER DNA TOPOISOMERASE II-ALPHA GENE
Authors: NG SW EDER JP SCHNIPPER LE CHAN VTW
Citation: Sw. Ng et al., MOLECULAR-CLONING AND CHARACTERIZATION OF THE PROMOTER FOR THE CHINESE-HAMSTER DNA TOPOISOMERASE II-ALPHA GENE, The Journal of biological chemistry, 270(43), 1995, pp. 25850-25858
DNA TOPOISOMERASE-II-ALPHA EXPRESSION IS ASSOCIATED WITH ALKYLATING AGENT RESISTANCE
Authors: EDER JP CHAN VTW NG SW RIZVI NA ZACHAROULIS S TEICHER BA SCHNIPPER LE
Citation: Jp. Eder et al., DNA TOPOISOMERASE-II-ALPHA EXPRESSION IS ASSOCIATED WITH ALKYLATING AGENT RESISTANCE, Cancer research, 55(24), 1995, pp. 6109-6116
PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE
Authors: WHEELER C STRAWDERMAN M AYASH L CHURCHILL WH BIERER BE ELIAS A GILLILAND DG ANTMAN K GUINAN EC EDER JP WEINSTEIN H SCHWARTZ G FERRARA J MAZANET R RIMM IJ TEPLER I MCCARTHY P MAUCH P AULT K GAYNES L MCCAULEY M SCHNIPPER LE ANTIN J
Citation: C. Wheeler et al., PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE, Journal of clinical oncology, 11(6), 1993, pp. 1085-1091
MODULATION OF ANTITUMOR ALKYLATING-AGENTS BY NOVOBIOCIN, TOPOTECAN, AND LONIDAMINE
Authors: SCHWARTZ GN TEICHER BA EDER JP HOLDEN SA ARA G HERMAN TS KORBUT T
Citation: Gn. Schwartz et al., MODULATION OF ANTITUMOR ALKYLATING-AGENTS BY NOVOBIOCIN, TOPOTECAN, AND LONIDAMINE, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 455-462
CONDITIONAL EXPRESSION OF WILD-TYPE TOPOISOMERASE-II COMPLEMENTS A MUTANT ENZYME IN MAMMALIAN-CELLS
Authors: EDER JP CHAN VTW NIEMIERKO E TEICHER BA SCHNIPPER LE
Citation: Jp. Eder et al., CONDITIONAL EXPRESSION OF WILD-TYPE TOPOISOMERASE-II COMPLEMENTS A MUTANT ENZYME IN MAMMALIAN-CELLS, The Journal of biological chemistry, 268(19), 1993, pp. 13844-13849
Risultati: 1-11 |